Noguchi M, Thomas M, Kitagawa H, Kinoshita K, Miyazaki I, Mizukami Y
KANAZAWA UNIV HOSP,SCH MED,DEPT SURG 2,KANAZAWA 920,JAPAN. KANAZAWA UNIV HOSP,SCH MED,PATHOL SECT,KANAZAWA 920,JAPAN.
Int J Oncol. 1993 Feb;2(2):265-9.
We evaluated the relationships among proliferative cell nuclear antigen (PCNA) expression, nucleolar organizer region (Ag-NOR) score and clinicopathologic variables, and their prognostic value, in 95 patients with breast cancer. PCNA expression was not found to be significantly associated with Ag-NOR score or with established clinicopathologic prognostic factors with the exception of histologic grade. Moreover, univariate and multivariate analyses showed that PCNA expression did not appear to be a significant prognostic factor, while Ag-NOR score was a significant prognostic factor only by univariate analysis. We therefore, concluded that PCNA expression may not be a useful prognostic factor in breast cancer.
我们评估了95例乳腺癌患者中增殖细胞核抗原(PCNA)表达、核仁组织区(Ag-NOR)评分与临床病理变量之间的关系及其预后价值。除组织学分级外,未发现PCNA表达与Ag-NOR评分或既定的临床病理预后因素有显著相关性。此外,单因素和多因素分析表明,PCNA表达似乎不是一个显著的预后因素,而Ag-NOR评分仅在单因素分析中是一个显著的预后因素。因此,我们得出结论,PCNA表达可能不是乳腺癌有用的预后因素。